Brought to you by 
Cytyc sells $220mm of convertible notes
01 Apr 2004
Executive Summary
Cytyc (women's health diagnostics) raised $220mm through the sale of 2.25% convertible notes due in 2024. The notes convert into common shares at a price of $29.67 each.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cytyc sells $220mm of convertible notes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice